PN
Pramod Narain Sinha
About Pramod Narain Sinha
Data last updated:
Pramod Narain Sinha is a Director at Lenore Pharmaceuticals Private Limited (since 2019). The companies operate in Trading and Healthcare. Lenore Pharmaceuticals Private Limited reported revenue of ₹1.50 Cr (FY 2024). Earlier, Pramod Narain Sinha was a Director at Medicatia Pharmaceuticals Private Limited (2018–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Oct 2019 | 2019 | ₹1.50 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Aug 2018 | 2018 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pramod Narain Sinha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Poonam Sinha | 06452468 | Lenore Pharmaceuticals Private Limited | Director |
| Shikha Srivastava | 08588720 | Lenore Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pramod Narain Sinha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pramod Narain Sinha
Pramod Narain Sinha currently holds 1 directorship: Lenore Pharmaceuticals Private Limited (Director, since 16 Oct 2019, revenue ₹1.50 Cr (FY 2024)).
Pramod Narain Sinha was first appointed on 10 Aug 2018 as Director at Medicatia Pharmaceuticals Private Limited. The most recent appointment on record is 16 Oct 2019 at Lenore Pharmaceuticals Private Limited.
Pramod Narain Sinha held 1 earlier board appointment: Medicatia Pharmaceuticals Private Limited (Director, 10 Aug 2018 to 04 Jun 2019).
The current boards of Pramod Narain Sinha's companies include Poonam Sinha (Lenore Pharmaceuticals Private Limited), Shikha Srivastava (Lenore Pharmaceuticals Private Limited).